193 related articles for article (PubMed ID: 22083803)
21. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
[TBL] [Abstract][Full Text] [Related]
22. Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.
Michałowska M; Chalimoniuk M; Jówko E; Przybylska I; Langfort J; Toczylowska B; Krygowska-Wajs A; Fiszer U
Brain Behav; 2020 Mar; 10(3):e01537. PubMed ID: 32022467
[TBL] [Abstract][Full Text] [Related]
23. Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease.
Lee JY; Cho J; Lee EK; Park SS; Jeon BS
Mov Disord; 2011 Jan; 26(1):73-9. PubMed ID: 20945430
[TBL] [Abstract][Full Text] [Related]
24. Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease.
Watanabe M; Harada S; Nakamura T; Ohkoshi N; Yoshizawa K; Hayashi A; Shoji S
Neuropsychobiology; 2003; 48(4):190-3. PubMed ID: 14673217
[TBL] [Abstract][Full Text] [Related]
25. Daytime sleepiness and the COMT val158met polymorphism in patients with Parkinson disease.
Rissling I; Frauscher B; Kronenberg F; Tafti M; Stiasny-Kolster K; Robyr AC; Körner Y; Oertel WH; Poewe W; Högl B; Möller JC
Sleep; 2006 Jan; 29(1):108-11. PubMed ID: 16453988
[TBL] [Abstract][Full Text] [Related]
26. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
Bosia M; Bechi M; Marino E; Anselmetti S; Poletti S; Cocchi F; Smeraldi E; Cavallaro R
Neurosci Lett; 2007 May; 417(3):271-4. PubMed ID: 17383818
[TBL] [Abstract][Full Text] [Related]
27. Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
Hoogland J; de Bie RM; Williams-Gray CH; Muslimović D; Schmand B; Post B
Mov Disord; 2010 Nov; 25(15):2550-4. PubMed ID: 20878993
[TBL] [Abstract][Full Text] [Related]
28. Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.
Hao H; Shao M; An J; Chen C; Feng X; Xie S; Gu Z; Chan P;
Parkinsonism Relat Disord; 2014 Oct; 20(10):1041-5. PubMed ID: 25034874
[TBL] [Abstract][Full Text] [Related]
29. Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis.
Pelayo-Terán JM; Pérez-Iglesias R; Vázquez-Bourgon J; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
Psychiatry Res; 2011 Jan; 185(1-2):286-9. PubMed ID: 20591499
[TBL] [Abstract][Full Text] [Related]
30. Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults.
de Frias CM; Annerbrink K; Westberg L; Eriksson E; Adolfsson R; Nilsson LG
J Cogn Neurosci; 2005 Jul; 17(7):1018-25. PubMed ID: 16102234
[TBL] [Abstract][Full Text] [Related]
31. Catechol-O-methyltransferase Val158Met polymorphism (rs4680) is associated with pain in multiple sclerosis.
Fernández-de-las-Peñas C; Ambite-Quesada S; Ortíz-Gutiérrez R; Ortega-Santiago R; Gil-Crujera A; Caminero AB
J Pain; 2013 Dec; 14(12):1719-23. PubMed ID: 24290452
[TBL] [Abstract][Full Text] [Related]
32. The COMT val158met polymorphism is associated with prevalent fractures in Swedish men.
Eriksson AL; Mellström D; Lorentzon M; Orwoll ES; Redlund-Johnell I; Grundberg E; Holmberg A; Ljunggren O; Karlsson MK; Ohlsson C
Bone; 2008 Jan; 42(1):107-12. PubMed ID: 17962094
[TBL] [Abstract][Full Text] [Related]
33. Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients.
Lee HY; Kim YK
Psychiatry Res; 2010 Jan; 175(1-2):63-6. PubMed ID: 20004480
[TBL] [Abstract][Full Text] [Related]
34. Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.
Białecka M; Droździk M; Honczarenko K; Gawrońska-Szklarz B; Stankiewicz J; Dabrowska E; Kubisiak M; Kłodowska-Duda G; Opala G
Eur Neurol; 2005; 53(2):68-73. PubMed ID: 15753616
[TBL] [Abstract][Full Text] [Related]
35. Asymmetry of prefrontal cortex activities and catechol-O-methyltransferase Val158Met genotype in patients with panic disorder during a verbal fluency task: near-infrared spectroscopy study.
Tanii H; Nishimura Y; Inoue K; Koshimizu H; Matsumoto R; Takami T; Hara N; Nishida A; Okada M; Kaiya H; Okazaki Y
Neurosci Lett; 2009 Mar; 452(1):63-7. PubMed ID: 19429001
[TBL] [Abstract][Full Text] [Related]
36. No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase.
Hoda F; Nicholl D; Bennett P; Arranz M; Aitchison KJ; al-Chalabi A; Kunugi H; Vallada H; Leigh PN; Chaudhuri KR; Collier DA
Biochem Biophys Res Commun; 1996 Nov; 228(3):780-4. PubMed ID: 8941353
[TBL] [Abstract][Full Text] [Related]
37. Dopaminergic denervation severity depends on COMT Val158Met polymorphism in Parkinson's disease.
Muellner J; Gharrad I; Habert MO; Kas A; Martini JB; Cormier-Dequaire F; Tahiri K; Vidailhet M; Meier N; Brice A; Schuepbach M; Mallet A; Hartmann A; Corvol JC
Parkinsonism Relat Disord; 2015 May; 21(5):471-6. PubMed ID: 25753458
[TBL] [Abstract][Full Text] [Related]
38. [No association between catechol-O-methyltransferase val158met polymorphism and alexithymia].
Hermes S; Hennig J; Stingl M; Leichsenring F; Leweke F
Z Psychosom Med Psychother; 2011; 57(1):51-61. PubMed ID: 21432838
[TBL] [Abstract][Full Text] [Related]
39. Association of the COMT val158met variant with antidepressant treatment response in major depression.
Baune BT; Hohoff C; Berger K; Neumann A; Mortensen S; Roehrs T; Deckert J; Arolt V; Domschke K
Neuropsychopharmacology; 2008 Mar; 33(4):924-32. PubMed ID: 17522626
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
